Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis

被引:171
作者
Jinde, K
Nikolic-Paterson, DJ
Huang, XR
Sakai, H
Kurokawa, K
Atkins, RC
Lan, HY
机构
[1] Tokai Univ, Sch Med, Dept Nephrol, Isehara, Kanagawa 25911, Japan
[2] Monash Med Ctr, Dept Nephrol, Clayton, Vic 3168, Australia
[3] Monash Univ, Dept Med, Clayton, Vic 3168, Australia
[4] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
关键词
glomerulonephritis; transdifferentiation; epithelial; myofibroblast; fibrosis; alpha-smooth muscle actin (alpha-SMA); cytokeratin; transforming growth factor-beta (TGF-beta);
D O I
10.1053/ajkd.2001.27693
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
There is much debate over the origins of fibroblast-type cells that accumulate in interstitial fibrosis. A controversial hypothesis, supported by data from animal and cell-culture studies, is that fibroblast-type cells can derive from tubular epithelial cells by a process of epithelial-mesenchymal transdifferentiation. However, to date, no evidence supports this postulate in human glomerulonephritis. This study sought to provide evidence that tubular epithelial cells can undergo phenotypic change toward a fibroblast-like cell in human glomerulonephritis. One hundred twenty-seven open renal biopsy specimens from patients with minimal change disease (MCD), immunoglobulin A (IgA) nephropathy, and rapidly progressive glomerulonephritis (RPGN) were examined for tubular phenotypic change by two-color immunohistochemistry using the criteria of de novo expression of a-smooth muscle actin (alpha -SMA), a myofibroblast marker; loss of the epithelial marker cytokeratin; and collagen production. In normal human kidney and MCD, tubular epithelial cells expressed cytokeratin with no evidence of alpha -SMA staining. However, in 36 of 90 cases of IgA nephropathy and 9 of 18 cases of RPGN, small numbers of tubular epithelial cells in areas of fibrosis showed de novo a-SMA expression, accounting for 0.4% +/- 0.2% (IgA nephropathy) and 3.8% +/- 1.5% (RPGN) of cortical tubules. An intermediate stage of phenotypic change was observed in some cuboidal epithelial cells that expressed both cytokeratin and alpha -SMA. Tubules containing alpha -SMA-positive (alpha -SMA(+)) cells also stained for collagen types I and III, suggesting that tubular cells undergoing phenotypic change have an active role in the fibrotic process. There also was a marked increase in transforming growth factor-beta1 (TGF-beta1) tubular expression in areas with interstitial fibrosis, including tubules with phenotypic change. There was a highly significant correlation between tubular a-SMA expression and interstitial fibrosis, interstitial a-SMA+ myofibroblast accumulation, deposition of collagen types I and III, tubular TGF-beta1 expression, and renal dysfunction. In conclusion, this study provides evidence that tubular epithelial cells can undergo phenotypic change toward a myofibroblast-like phenotype on the basis of de novo a-SMA expression, loss of cytokeratin, and de novo collagen staining. These data, although not conclusive, provide the first support for the hypothesis that transdifferentiation of tubular epithelial cells has a role in progressive renal fibrosis in human glomerulonephritis. (C) 2001 by the National Kidney Foundation, Inc.
引用
收藏
页码:761 / 769
页数:9
相关论文
共 33 条
[1]   ENHANCED EXPRESSION OF MUSCLE-SPECIFIC ACTIN IN GLOMERULONEPHRITIS [J].
ALPERS, CE ;
HUDKINS, KL ;
GOWN, AM ;
JOHNSON, RJ .
KIDNEY INTERNATIONAL, 1992, 41 (05) :1134-1142
[2]  
ALPERS CE, 1994, J AM SOC NEPHROL, V5, P201
[3]  
Badid C, 2000, HISTOL HISTOPATHOL, V15, P269, DOI 10.14670/HH-15.269
[4]  
Badid C, 1999, CLIN NEPHROL, V52, P210
[5]   NATURAL INHIBITOR OF TRANSFORMING GROWTH-FACTOR-BETA PROTECTS AGAINST SCARRING IN EXPERIMENTAL KIDNEY-DISEASE [J].
BORDER, WA ;
NOBLE, NA ;
YAMAMOTO, T ;
HARPER, JR ;
YAMAGUCHI, Y ;
PIERSCHBACHER, MD ;
RUOSLAHTI, E .
NATURE, 1992, 360 (6402) :361-364
[6]  
CLARKSON AR, 1996, DIS KIDNEY, P1645
[7]  
DIAMOND JR, 1995, AM J PATHOL, V146, P121
[8]   ONTOGENY OF TUBULOINTERSTITIAL CELLS [J].
EKBLOM, P ;
WELLER, A .
KIDNEY INTERNATIONAL, 1991, 39 (03) :394-400
[9]   Myofibroblasts and the progression of diabetic nephropathy [J].
Essawy, M ;
Soylemezoglu, O ;
MuchanetaKubara, EC ;
Shortland, J ;
Brown, CB ;
ElNahas, AM .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (01) :43-50
[10]   Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro [J].
Fan, JM ;
Ng, YY ;
Hill, PA ;
Nikolic-Paterson, DJ ;
Mu, W ;
Atkins, RC ;
Lan, HY .
KIDNEY INTERNATIONAL, 1999, 56 (04) :1455-1467